Showing results (171-180 of 206) with videos related to
Sort By:
Pageof 21
Pharmacotherapy|March 7, 2012
Distressing adverse events after antidepressant switch in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: influence of adverse events during initial treatment with citalopram on development of subsequent adverse events with an alternative antidepressantAaron J Katz, Stacie B Dusetzina, Joel F Farley, et al.Medical Care|September 5, 2014
High-risk medication use by nursing home residents before and after hospitalizationDavid G Stevenson, Stacie B Dusetzina, A James O'Malley, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 13, 2022
The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch upAndrew Etteldorf, Ramy Sedhom, Shannon M Rotolo, et al.The Oncologist|April 17, 2015
The project data sphere initiative: accelerating cancer research by sharing dataAngela K Green, Katherine E Reeder-Hayes, Robert W Corty, et al.Journal of Managed Care & Specialty Pharmacy|August 1, 2024
A primer on copay accumulators, copay maximizers, and alternative funding programsDavid Choi, Autumn D Zuckerman, Svetlana Gerzenshtein, et al.Medical Care|September 13, 2013
Medicare Part D plan generosity and medication use among dual-eligible nursing home residentsHaiden A Huskamp, David G Stevenson, A James O'Malley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2015
Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast CancerMegan C Roberts, Morris Weinberger, Stacie B Dusetzina, et al.Journal of the American Geriatrics Society|August 16, 2014
Effect of Part D coverage restrictions for antidepressants, antipsychotics, and cholinesterase inhibitors on related nursing home resident outcomesDavid G Stevenson, A James O'Malley, Stacie B Dusetzina, et al.Breast Cancer Research and Treatment|July 29, 2015
Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testingMegan C Roberts, Morris Weinberger, Stacie B Dusetzina, et al.Psychiatric Services (Washington, D.C.)|January 16, 2013
Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008Rachel Kornfield, Sydeaka Watson, Ashley S Higashi, et al.Pageof 21